REVIEW
|
doi:10.20944/preprints202306.0994.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
hepatocellular carcinoma (HCC); LOXL2; tumor microenvironment (TME); extracellular matrix (ECM); LOXL2 inhibitors; target therapy
Online: 14 June 2023 (07:18:34 CEST)